Cargando…

Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations

BACKGROUND: Few previous studies of metabolic aberrations and prostate cancer risk have taken into account the fact that men with metabolic aberrations have an increased risk of death from causes other than prostate cancer. The aim of this study was to calculate, in a real-life scenario, the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Häggström, Christel, Stocks, Tanja, Nagel, Gabriele, Manjer, Jonas, Bjørge, Tone, Hallmans, Göran, Engeland, Anders, Ulmer, Hanno, Lindkvist, Björn, Selmer, Randi, Concin, Hans, Tretli, Steinar, Jonsson, Håkan, Stattin, Pär
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222792/ https://www.ncbi.nlm.nih.gov/pubmed/25207955 http://dx.doi.org/10.1097/EDE.0000000000000174

Ejemplares similares

Pooled cohort study on height and risk of cancer and cancer death
por: Wirén, Sara, et al.
Publicado: (2013)

Metabolic risk score and cancer risk: pooled analysis of seven cohorts
por: Stocks, Tanja, et al.
Publicado: (2015)

Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580 000 subjects within the Me-Can project
por: Lindkvist, Björn, et al.
Publicado: (2014)

A Prospective Study on Metabolic Risk Factors and Gallbladder Cancer in the Metabolic Syndrome and Cancer (Me-Can) Collaborative Study
por: Borena, Wegene, et al.
Publicado: (2014)

Metabolic Factors Associated with Risk of Renal Cell Carcinoma
por: Häggström, Christel, et al.
Publicado: (2013)

Correction: Metabolic Factors Associated with Risk of Renal Cell Carcinoma
por: Häggström, Christel, et al.
Publicado: (2013)

Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can)
por: Strohmaier, Susanne, et al.
Publicado: (2013)

Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
por: Stocks, Tanja, et al.
Publicado: (2009)

Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
por: Stocks, Tanja, et al.
Publicado: (2010)

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
por: Sun, Ming, et al.
Publicado: (2023)

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
por: Jochems, Sylvia H. J., et al.
Publicado: (2023)

Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
por: Engeland, A, et al.
Publicado: (2003)

Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
por: Van Hemelrijck, Mieke, et al.
Publicado: (2018)

Reply: Height, body mass index, and prostate cancer – a follow-up of 950 000 Norwegian men
por: Engeland, A, et al.
Publicado: (2004)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

Interaction of leisure‐time physical activity with body mass index on the risk of obesity‐related cancers: A pooled study
por: Sun, Ming, et al.
Publicado: (2022)

Prostate specific antigen for early detection of prostate cancer: longitudinal study
por: Holmström, Benny, et al.
Publicado: (2009)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population‐based study
por: Tomic, Katarina, et al.
Publicado: (2018)

Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence
por: Stattin, Pär, et al.
Publicado: (2014)

Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women
por: Bjørge, T, et al.
Publicado: (2005)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study
por: Bjørge, T, et al.
Publicado: (2008)

Association between serum 25(OH)D and death from prostate cancer
por: Tretli, S, et al.
Publicado: (2009)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancer
por: Forster, Rachel B., et al.
Publicado: (2022)

γ-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors – A Pooled Cohort Analysis
por: Preyer, Oliver, et al.
Publicado: (2016)

Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study
por: Thomsen, Frederik B., et al.
Publicado: (2021)

Body size and thyroid cancer in two million Norwegian men and women
por: Engeland, A, et al.
Publicado: (2006)

Associations between prediagnostic blood glucose levels, diabetes, and glioma
por: Schwartzbaum, Judith, et al.
Publicado: (2017)

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study
por: Vickers, Andrew J, et al.
Publicado: (2010)

Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study
por: Bjørge, Tone, et al.
Publicado: (2016)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
por: Hägglöf, Christina, et al.
Publicado: (2010)

Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: A study from the National Prostate Cancer Register (NPCR) of Sweden
por: Fridriksson, Jon, et al.
Publicado: (2012)

Paternal characteristics associated with maternal periconceptional use of folic acid supplementation
por: Mortensen, Jan Helge Seglem, et al.
Publicado: (2018)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
por: Thurtle, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmd28bbg56bbdvmrl8ootkhppo